PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine0 citations

B63-08 PJP and Air Leak Syndrome in an Infant: A Rare Presentation

View Full Paper
MBM O BowmanSMS A Mcgrath-MorrowJFJ Fierro

Key Points

  • This case aims to discuss a rare presentation of respiratory distress due to air leak syndrome caused by Pneumocystis jirovecii pneumonia in a previously healthy infant.
  • Describes a case of a three-month-old male presenting with respiratory distress and diagnosed with pneumomediastinum and a tension pneumothorax.
  • Evaluated with chest x-ray, HRCT, and genetic testing for X-linked agammaglobulinemia candidate variant.
  • Managed with antibiotics, corticosteroids, and endotracheal intubation, followed by bronchoalveolar lavage for PJP sampling.
  • Patient diagnosed with XLA and PJP; developed pneumomediastinum and tension pneumothorax.
  • After initial management, required intubation and treatment with Bactrim, resulting in rapid clinical improvement.
  • Discharged after chest tube removal and feeding rehabilitation with monthly IVIG for XLA.

Abstract

Abstract Introduction Pneumothorax and pneumomediastinum are examples of air leak syndromes, where air enters extra-pulmonary spaces due to alveolar and airway rupture. These complications are uncommon in a healthy infant. This study describes a three-month-old male who presented with respiratory distress, found to have pneumomediastinum and tension pneumothorax. Thorough evaluation revealed a diagnosis of X-linked agammaglobulinemia (XLA) with concurrent Pneumocystis jirovecii pneumonia (PJP) as the etiology for his respiratory failure and air leak. Case A three-month-old male born at 37 weeks gestation presented to an emergency department for new onset respiratory distress. He had normal newborn screening and no trauma history. Chest x-ray and confirmatory chest high-resolution CT (HRCT) demonstrated spontaneous pneumomediastinum (Figure 1A/B). Viral and bacterial testing were unremarkable. A sweat test and echocardiogram were normal. A video fluoroscopic swallow study showed trace aspiration and reflux without a clear etiology of his dysphagia. He initially weaned from high flow to low flow nasal cannula as his respiratory status improved with antibiotics and corticosteroids. However, he again developed respiratory distress three weeks later. A repeat HRCT supported worsening air leak (Figure 1C/D). His acute decompensation required endotracheal intubation, needle decompression for tension pneumothorax, and high frequency jet ventilation (HFJV). Genetic testing revealed a pathogenic variant for XLA. After hospital transfer for continued management, he transitioned back to conventional mechanical ventilation. Endotracheal tube sputum was obtained and resulted positive for PJP by PCR. Bactrim was initiated for treatment with rapid clinical improvement. Flexible bronchoscopy with bronchoalveolar lavage was performed to obtain PJP PCR sampling after better clinical stability; this resulted positive. He later extubated and weaned to room air after chest tube removal. The patient discharged home with feeding rehabilitation and monthly IVIG treatments for XLA. Conclusion Here, we describe a rare presentation of PJP in an infant with newly diagnosed immunodeficiency presenting with air leak. P. jiroveci is an opportunistic fungal infection often seen in patients with HIV or in non-HIV patients with immunodeficiency or transplant history. Typical PJP imaging demonstrates ground glass attenuation. Although XLA is a primary humoral immunodeficiency characterized by recurrent bacterial infections, as maternal placental antibodies wean, these patients can develop PJP despite normal T-cell number and function. Pneumomediastinum or pneumothorax are rare complications of severe PJP seen in 2-4% of non-HIV patients, and the etiology remains unclear. Timely diagnosis of PJP is crucial to prevent significant morbidity and mortality. Bactrim remains the gold standard treatment. This abstract is funded by: None

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bowman et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5098f03e14405aa9c91bhttps://doi.org/10.1093/ajrccm/aamag162.4256
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1B63-06 Pneumomediastinum and Pulmonary Interstitial Emphysema as a Presenting Symptom of Pneumocystis Jiroveci Infection in X-linked Agammaglobulinemia2026
  2. 2Severe Pneumocystis jirovecii Pneumonia in an Apparently Immunocompetent Child Complicated by Acute Respiratory Distress Syndrome and Air Leak Syndrome: A Case Report and Literature Review2026
  3. 3[An infant with leukemia complicated by Pneumocystisjirovecii pneumonia: A case report and literature review].2025
  4. 4B72-34 Consider, Evaluate, and Treat for Pneumocystis Jirovecii Pneumonia Regardless of Presumed Immunocompetent Status2026
  5. 5A69-02 When One Infection Isn’t Enough: Severe PJP With Bilateral Pneumothoraces and MAC Co-infection in Newly Diagnosed HIV2026